Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Cutler RE Jr"'
Autor:
Alshad S. Lalani, Rebecca J. Nagy, Richard E. Cutler, Eric H. Bernicker, Carlos L. Arteaga, Nick V. Grishin, Aju Mathew, Sarah Croessmann, Lisa N. Kinch, Paula I. Gonzalez-Ericsson, Massimo Cristofanilli, Luigi Formisano, Jie He, Vincent A. Miller, Richard B. Lanman, Dhivya R. Sudhan
Purpose: We examined the role of ERBB2-activating mutations in endocrine therapy resistance in estrogen receptor positive (ER+) breast cancer. Experimental Design: ERBB2 mutation frequency was determined from large genomic databases. Isogenic knock-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85a503b2ade4c0662de8574ca2fd605f
https://europepmc.org/articles/PMC6320312/
https://europepmc.org/articles/PMC6320312/
Autor:
Sudhan DR, Guerrero-Zotano A, Won H, Ericsson PG, Servetto A, Huerta-Rosario M, Ye D, Lee KM, Formisano L, Guo Y, Liu Q, Kinch LN, Brewer MR, Dugger T, Koch J, Wick MJ, Cutler RE Jr, Lalani AS, Bryce R, Auerbach A, Hanker AB, Arteaga CL
Publikováno v:
Cancer cell [Cancer Cell] 2020 Feb 10; Vol. 37 (2), pp. 258-259.
Autor:
Booth L; Departments of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Roberts JL; Departments of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Rais R; Departments of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Cutler RE Jr; Puma Biotechnology Inc., Los Angeles, California, University of Texas Health Science Center, Houston, Texas., Diala I; Puma Biotechnology Inc., Los Angeles, California, University of Texas Health Science Center, Houston, Texas., Lalani AS; Puma Biotechnology Inc., Los Angeles, California, University of Texas Health Science Center, Houston, Texas., Hancock JF; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas., Poklepovic A; Medicine, Virginia Commonwealth University, Richmond, Virginia., Dent P; Departments of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia.
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2019 Apr; Vol. 234 (4), pp. 4874-4887. Date of Electronic Publication: 2018 Sep 10.
Autor:
Ou Y; Amgen Inc., South San Francisco, CA, USA., Xu Y; Amgen Inc., Thousand Oaks, CA, USA., Gore L; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Harvey RD; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Mita A; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA., Wang Z; Amgen Inc., South San Francisco, CA, USA., Cutler RE Jr; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA., Pinchasik DE; Amgen Inc., South San Francisco, CA, USA., Tsimberidou AM; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Mar; Vol. 85 (3), pp. 530-539. Date of Electronic Publication: 2018 Dec 25.
Autor:
Hyman DM; Memorial Sloan Kettering Cancer Center, New York, New York, USA. hymand@mskcc.org., Piha-Paul SA; University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Won H; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Rodon J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Saura C; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Shapiro GI; Dana-Faber Cancer Institute, Boston, Massachusetts, USA., Juric D; Massachusetts Hospital Cancer Center, Boston, Massachusetts, USA., Quinn DI; USC Norris Comprehensive Cancer Center, Los Angeles, California, USA., Moreno V; START Madrid Fundación Jímenez Díaz, Madrid, Spain., Doger B; START Madrid Fundación Jímenez Díaz, Madrid, Spain., Mayer IA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Boni V; START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain., Calvo E; START Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain., Loi S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lockhart AC; Washington University in St. Louis School of Medicine, St Louis, Missouri, USA., Erinjeri JP; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Scaltriti M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Ulaner GA; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Patel J; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Tang J; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Beer H; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Selcuklu SD; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hanrahan AJ; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bouvier N; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Melcer M; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Murali R; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Smyth LM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Li BT; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Drilon A; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Harding JJ; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Iyer G; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Taylor BS; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Berger MF; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Cutler RE Jr; Puma Biotechnology Inc., Los Angeles, California, USA., Xu F; Puma Biotechnology Inc., Los Angeles, California, USA., Butturini A; Puma Biotechnology Inc., Los Angeles, California, USA., Eli LD; Puma Biotechnology Inc., Los Angeles, California, USA., Mann G; Puma Biotechnology Inc., Los Angeles, California, USA., Farrell C; Puma Biotechnology Inc., Los Angeles, California, USA., Lalani AS; Puma Biotechnology Inc., Los Angeles, California, USA., Bryce RP; Puma Biotechnology Inc., Los Angeles, California, USA., Arteaga CL; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Meric-Bernstam F; University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Baselga J; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Solit DB; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Publikováno v:
Nature [Nature] 2019 Feb; Vol. 566 (7745), pp. E11-E12.
Autor:
Jongen L; Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium., Floris G; Laboratory of Translational Cell & Tissue Research, Department of Imaging and Pathology, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium.; Department of Pathology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium., Boeckx B; Department of Human Genetics, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium.; Laboratory of Translational Genetics, VIB Center for Cancer Biology, Herestraat 49, 3000, Leuven, Belgium., Smeets D; Department of Human Genetics, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium.; Laboratory of Translational Genetics, VIB Center for Cancer Biology, Herestraat 49, 3000, Leuven, Belgium., Lambrechts D; Department of Human Genetics, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium.; Laboratory of Translational Genetics, VIB Center for Cancer Biology, Herestraat 49, 3000, Leuven, Belgium., Vander Borght S; Department of Pathology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.; Department of Human Genetics, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium., Laenen A; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Belgium., Mann G; Puma Biotechnology, Inc., 10880 Wilshire Blvd., Suite 2150, Los Angeles, CA, 90024, USA., Cutler RE Jr; Puma Biotechnology, Inc., 10880 Wilshire Blvd., Suite 2150, Los Angeles, CA, 90024, USA., Lalani AS; Puma Biotechnology, Inc., 10880 Wilshire Blvd., Suite 2150, Los Angeles, CA, 90024, USA., Neven P; Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium.; Department of Gynaecology and Obstetrics, University Hospitals Leuven, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium., Wildiers H; Department of Oncology, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium. hans.wildiers@uzleuven.be.; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven - University of Leuven, Herestraat 49, 3000, Leuven, Belgium. hans.wildiers@uzleuven.be.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Feb; Vol. 174 (1), pp. 55-63. Date of Electronic Publication: 2018 Nov 19.
Autor:
Hanker AB, Brewer MR, Sheehan JH, Koch JP, Sliwoski GR, Nagy R, Lanman R, Berger MF, Hyman DM, Solit DB, He J, Miller V, Cutler RE Jr, Lalani AS, Cross D, Lovly CM, Meiler J, Arteaga CL
Publikováno v:
Cancer discovery [Cancer Discov] 2019 Feb; Vol. 9 (2), pp. 303.
Autor:
Booth L; a Departments of Biochemistry and Molecular Biology , Virginia Commonwealth University , Richmond , VA , USA., Roberts JL; a Departments of Biochemistry and Molecular Biology , Virginia Commonwealth University , Richmond , VA , USA., Rais R; a Departments of Biochemistry and Molecular Biology , Virginia Commonwealth University , Richmond , VA , USA., Cutler RE Jr; c Puma Biotechnology Inc ., Los Angeles , CA , USA., Diala I; c Puma Biotechnology Inc ., Los Angeles , CA , USA., Lalani AS; c Puma Biotechnology Inc ., Los Angeles , CA , USA., Poklepovic A; b Medicine , Virginia Commonwealth University , Richmond , VA , USA., Dent P; a Departments of Biochemistry and Molecular Biology , Virginia Commonwealth University , Richmond , VA , USA.
Publikováno v:
Cancer biology & therapy [Cancer Biol Ther] 2019; Vol. 20 (2), pp. 157-168. Date of Electronic Publication: 2018 Sep 05.
Autor:
Croessmann S; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Formisano L; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Kinch LN; Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas., Gonzalez-Ericsson PI; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Sudhan DR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Nagy RJ; Guardant Health, Inc., Redwood, California., Mathew A; University of Kentucky Markey Cancer Center, Lexington, Kentucky., Bernicker EH; Houston Methodist Cancer Center, Houston, Texas., Cristofanilli M; Lurie Comprehensive Cancer Center, Chicago, Illinois., He J; Foundation Medicine, Inc., Cambridge, Massachusetts., Cutler RE Jr; Puma Biotechnology, Inc., Los Angeles, California., Lalani AS; Puma Biotechnology, Inc., Los Angeles, California., Miller VA; Foundation Medicine, Inc., Cambridge, Massachusetts., Lanman RB; Guardant Health, Inc., Redwood, California., Grishin NV; Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, Texas.; Department of Biophysics, UT Southwestern Medical Center, Dallas, Texas.; Department of Biochemistry, UT Southwestern Medical Center, Dallas, Texas., Arteaga CL; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. carlos.arteaga@utsouthwestern.edu.; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jan 01; Vol. 25 (1), pp. 277-289. Date of Electronic Publication: 2018 Oct 12.
Autor:
Cocco E; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Javier Carmona F; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Razavi P; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Won HH; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Cai Y; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Rossi V; Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy., Chan C; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Cownie J; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Soong J; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Toska E; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Shifman SG; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Sarotto I; Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy., Savas P; Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia., Wick MJ; START, 4383 Medical Dr, San Antonio, TX 78229, USA., Papadopoulos KP; START, 4383 Medical Dr, San Antonio, TX 78229, USA., Moriarty A; START, 4383 Medical Dr, San Antonio, TX 78229, USA., Cutler RE Jr; Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA., Avogadri-Connors F; Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA., Lalani AS; Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA., Bryce RP; Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA., Chandarlapaty S; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Solit DB; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Boni V; START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain., Loi S; Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia., Baselga J; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Berger MF; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Montemurro F; Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. filippo.montemurro@ircc.it scaltrim@mskcc.org., Scaltriti M; Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. filippo.montemurro@ircc.it scaltrim@mskcc.org.; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Publikováno v:
Science signaling [Sci Signal] 2018 Oct 09; Vol. 11 (551). Date of Electronic Publication: 2018 Oct 09.